Reports

Sale

Direct-To-Consumer Laboratory Testing Market

Global Direct-To-Consumer Laboratory Testing Market Share: By Sample Type: Blood, Urine, Saliva, Others; By Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, Others; By Distribution Channel: Online Platforms/Websites, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Direct-To-Consumer Laboratory Testing Market Outlook

The global direct-to-consumer laboratory testing market size was valued at USD 12.4 billion in 2023, driven by the rising prevalence of telemedicine and EHR services across the globe. The market is expected to grow at a CAGR of 26.8% during the forecast period of 2024-2032, with the values likely to rise from USD 15.7 billion in 2024 to USD 105 billion by 2032.

 

Direct-To-Consumer Laboratory Testing: Introduction

Direct to consumer laboratory testing involves providing the customer with a generated lab test, where they get direct results from the test without engaging with a physician. It has gained high popularity owing to their rapid, accurate and convenient results. DTC testing may not be available for all diseases but they can help in monitoring a prevailing health condition or identify an infectious disease like COVID-19.

 

Global Direct-To-Consumer Laboratory Testing Market Analysis

Direct to customer lab tests have become highly common after the sudden outbreak of COVID-19. People have become more familiar and comfortable to at home lab tests. Apart from COVID-19, pregnancy test kits also hold a significant share of the market.

 

The direct-to-consumer laboratory testing market value is driven by the rising digital and artificial intelligence integration and EHR (electronic health record) prevalence. Local testing labs like LigoLab has launched their own consumer portal to facilitate prompt and convenient delivery of results. These platforms are HIPAA compliant and integrate other medical system software as well. With a vision to go beyond at-home testing, companies like Everly Health have been developing virtual care services for effective diagnostic testing, treatment, and ongoing condition management.

 

In July 2023, Quest Diagnostics launched the first direct to consumer blood test that works by detecting abnormal levels of beta amyloid. The test is aimed at adults aged 18 years or older with Alzheimer running in the family history or with mild dementia. If the results turn out to be positive, then the patient is directly contacted by a doctor. Such services are projected to fuel the direct to customer laboratory testing market growth in the upcoming years.

 

Global Direct-To-Consumer Laboratory Testing Market Segmentation

Market Breakup by Sample Type

  • Blood
  • Urine
  • Saliva
  • Others

 

Market Breakup by Test Type

  • Genetic Testing
  • Disease Risk Assessment Testing
  • CBC
  • Diabetes Testing
  • TSH Testing
  • Others

 

Market Breakup by Distribution Channel

  • Online Platforms/Websites
  • Mobile Applications
  • Physical Retail Locations
  • Telemedicine Services
  • Others

 

Market Breakup by End User

  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centres
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Direct-To-Consumer Laboratory Testing Market Overview

North America has held a major portion of the direct-to-consumer laboratory testing market share owing to a well organised medical infrastructure. Healthcare professionals have also worked on educating common people with appropriate utilisation of latest technologies. In addition, the increasing innovation due to presence of impactful healthcare companies is a major factor for driving growth. Europe is a key player holding significant part of the market size.

 

To meet the rising direct-to-consumer laboratory testing market demand, Asia Pacific region has been observing an increase in the at home test kits manufacturing. Being home to a massive percentage of geriatric population, direct-to-consumer laboratory tests come in handy as the older generation cannot physically move all the time. To ensure easy access to test results, the companies have started providing both soft and hard copy of the test results.

 

Global Direct-To-Consumer Laboratory Testing Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • LabCorp
  • Quest Diagnostics
  • Everlywell
  • LetsGetChecked
  • HealthTap
  • AncestryDNA
  • Veritas Genetics
  • MyHeritage
  • Color Genomics
  • Helix
  • Orig3n
  • Pathway Genomics
  • Thermo Fisher Scientific
  • Genome Medical
  • HealthCheck

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Sample Type
  • Test Type
  • Distribution Channel
  • End User
  • Region
Breakup by Sample Type
  • Blood
  • Urine
  • Saliva
  • Others
Breakup by Test Type
  • Genetic Testing
  • Disease Risk Assessment Testing
  • CBC
  • Diabetes Testing
  • TSH Testing
  • Others
Breakup by Distribution Channel
  • Online Platforms/Websites
  • Mobile Applications
  • Physical Retail Locations
  • Telemedicine Services
  • Others
Breakup by End User
  • Hospitals
  • Clinics
  • Speciality Labs
  • Diagnostic Centres
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • LabCorp
  • Quest Diagnostics
  • Everlywell
  • LetsGetChecked
  • HealthTap
  • AncestryDNA
  • Veritas Genetics
  • MyHeritage
  • Color Genomics
  • Helix
  • Orig3n
  • Pathway Genomics
  • Thermo Fisher Scientific
  • Genome Medical
  • HealthCheck

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Direct-to-Consumer Laboratory Testing Market Overview 

    3.1    Global Direct-to-Consumer Laboratory Testing Market Historical Value (2017-2023) 
    3.2    Global Direct-to-Consumer Laboratory Testing Market Forecast Value (2024-2032)
4    Global Direct-to-Consumer Laboratory Testing Market Landscape
    4.1    Global Direct-to-Consumer Laboratory Testing Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Direct-to-Consumer Laboratory Testing Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology 
5    Global Direct-to-Consumer Laboratory Testing Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Direct-to-Consumer Laboratory Testing Market Segmentation 
    6.1    Global Direct-to-Consumer Laboratory Testing Market by Sample Type
        6.1.1    Market Overview
        6.1.2    Blood
        6.1.3    Urine
        6.1.4    Saliva
        6.1.5    Others
    6.2    Global Direct-to-Consumer Laboratory Testing Market by Test Type
        6.2.1    Market Overview
        6.2.2    Genetic Testing
        6.2.3    Disease Risk Assessment Testing
        6.2.4    CBC
        6.2.5    Diabetes Testing
        6.2.6    TSH Testing
        6.2.7    Others
    6.3    Global Direct-to-Consumer Laboratory Testing Market by Distribution Channel
        6.3.1    Market Overview
        6.3.2    Online Platforms/Websites
        6.3.3    Mobile Applications
        6.3.4    Physical Retail Locations
        6.3.5    Telemedicine Services
        6.3.6    Others
    6.4    Global Direct-to-Consumer Laboratory Testing Market by End User
        6.4.1    Market Overview
        6.4.2    Hospitals
        6.4.3    Clinics
        6.4.4    Speciality Labs
        6.4.5    Diagnostic Centres
        6.4.6    Others
    6.5    Global Direct-to-Consumer Laboratory Testing Market by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Direct-to-Consumer Laboratory Testing Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Direct-to-Consumer Laboratory Testing Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Direct-to-Consumer Laboratory Testing Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Direct-to-Consumer Laboratory Testing Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Direct-to-Consumer Laboratory Testing Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    LabCorp
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisition
        17.1.5    Certifications
    17.2    Quest Diagnostics
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisition
        17.2.5    Certifications
    17.3    Everlywell
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisition
        17.3.5    Certifications
    17.4    LetsGetChecked
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisition
        17.4.5    Certifications
    17.5    HealthTap
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisition
        17.5.5    Certifications
    17.6    AncestryDNA
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisition
        17.6.5    Certifications
    17.7    Veritas Genetics
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisition
        17.7.5    Certifications
    17.8    MyHeritage
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisition
        17.8.5    Certifications
    17.9    Color Genomics
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisition
        17.9.5    Certifications
    17.10    Helix
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisition
        17.10.5    Certifications
    17.11    Orig3n
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisition
        17.11.5    Certifications
    17.12    Pathway Genomics
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisition
        17.12.5    Certifications
    17.13    Thermo Fisher Scientific 
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisition
        17.13.5    Certifications
    17.14    Genome Medical
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisition
        17.14.5    Certifications
    17.15    HealthCheck
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisition
        17.15.5    Certifications
18    Global Direct-to-Consumer Laboratory Testing Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 12.4 billion in 2023, driven by the increasing prevalence of EHR and telehealth services across the globe.

The market is anticipated to grow at a CAGR of 26.8% during the forecast period of 2024-2032, likely to reach a market value of USD 105 billion by 2032.

The market demand is driven by the rising convergence of digital and artificial intelligence aided platforms into the diagnostic testing areas, which has facilitated prompt, convenient and rapid results in patients.

The current market trend is about the increasing number of at home testing kits being launched for various diseases, which include acute diseases like Alzheimer. Quest Diagnostics launched the first direct to consumer blood test for detecting Alzheimer in patients in July 2023.

Blood, urine, saliva, and others are common sample types in the market.

Based on test type, the market is divided into genetic testing, disease risk assessment testing, CBC, diabetes testing, and TSH testing, among others.

Major distribution channels include online platforms/websites, mobile applications, physical retail locations, and telemedicine services, among others.

Major end users include hospitals, clinics, speciality labs, and diagnostic centres, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Key players involved in the market are LabCorp, Quest Diagnostics, Everlywell, LetsGetChecked, HealthTap, AncestryDNA, Veritas Genetics, MyHeritage, Color Genomics, Helix, Orig3n, Pathway Genomics, Thermo Fisher Scientific, Genome Medical and HealthCheck.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER